These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 29954145)

  • 1. In-Vitro Activity of Silybin and Related Flavonolignans against
    Olías-Molero AI; Jiménez-Antón MD; Biedermann D; Corral MJ; Alunda JM
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29954145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of allicin on promastigotes and intracellular amastigotes of Leishmania donovani and L. infantum.
    Jesús Corral-Caridad M; Moreno I; Toraño A; Domínguez M; Alunda JM
    Exp Parasitol; 2012 Dec; 132(4):475-82. PubMed ID: 22995646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effects of purine and pyrimidine analogues on Leishmania donovani and Leishmania infantum promastigotes and intracellular amastigotes.
    Azzouz S; Lawton P
    Acta Parasitol; 2017 Sep; 62(3):582-588. PubMed ID: 28682767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
    Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L
    Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs.
    Rastrojo A; García-Hernández R; Vargas P; Camacho E; Corvo L; Imamura H; Dujardin JC; Castanys S; Aguado B; Gamarro F; Requena JM
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):246-264. PubMed ID: 29689531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro synergistic effect of amphotericin B and allicin on Leishmania donovani and L. infantum.
    Corral MJ; González-Sánchez E; Cuquerella M; Alunda JM
    Antimicrob Agents Chemother; 2014; 58(3):1596-602. PubMed ID: 24366748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of a novel sulfonamide compound 2-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide against Leishmania donovani.
    Dikhit MR; Purkait B; Singh R; Sahoo BR; Kumar A; Kar RK; Ansari MY; Saini S; Abhishek K; Sahoo GC; Das S; Das P
    Drug Des Devel Ther; 2016; 10():1753-61. PubMed ID: 27307706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line.
    Jain SK; Sahu R; Walker LA; Tekwani BL
    J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of synergy between host and pathogen-directed therapies against intracellular Leishmania donovani.
    Zahid MSH; Johnson MM; Tokarski RJ; Satoskar AR; Fuchs JR; Bachelder EM; Ainslie KM
    Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():125-132. PubMed ID: 31493763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antileishmanial activity of thioridazine on amphotericin B unresponsive/ sensitive Leishmania donovani promastigotes and intracellular amastigotes.
    Kumar V; Kumari S; Ranjan R; Kumar A; Alti D
    Exp Parasitol; 2024 Feb; 257():108688. PubMed ID: 38142765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
    Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
    Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Chlorotaurine shows high in vitro activity against promastigotes and amastigotes of Leishmania species.
    Fürnkranz U; Nagl M; Gottardi W; Matt U; Aspöck H; Walochnik J
    J Med Microbiol; 2009 Oct; 58(Pt 10):1298-1302. PubMed ID: 19541788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Selection of Paromomycin and Miltefosine Resistance in Leishmania donovani and L. infantum in a Syrian Hamster Model.
    Hendrickx S; Mondelaers A; Eberhardt E; Delputte P; Cos P; Maes L
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4714-8. PubMed ID: 26014955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania donovani: assessment of leishmanicidal effects of herbal extracts obtained from plants in the visceral leishmaniasis endemic area of Bihar, India.
    Singh SK; Bimal S; Narayan S; Jee C; Bimal D; Das P; Bimal R
    Exp Parasitol; 2011 Feb; 127(2):552-8. PubMed ID: 21070771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro 'time-to-kill' assay to assess the cidal activity dynamics of current reference drugs against Leishmania donovani and Leishmania infantum.
    Maes L; Beyers J; Mondelaers A; Van den Kerkhof M; Eberhardt E; Caljon G; Hendrickx S
    J Antimicrob Chemother; 2017 Feb; 72(2):428-430. PubMed ID: 27707992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
    Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphotericin B inhibits entry of Leishmania donovani into primary macrophages.
    Paila YD; Saha B; Chattopadhyay A
    Biochem Biophys Res Commun; 2010 Aug; 399(3):429-33. PubMed ID: 20678487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum.
    Lage PS; Chávez-Fumagalli MA; Mesquita JT; Mata LM; Fernandes SO; Cardoso VN; Soto M; Tavares CA; Leite JP; Tempone AG; Coelho EA
    Parasitol Res; 2015 Dec; 114(12):4625-35. PubMed ID: 26346453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.